UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000018621
Receipt number R000021534
Scientific Title The analysis of immune response on the effect of endocrine therapy in breast cancer patients
Date of disclosure of the study information 2015/08/12
Last modified on 2015/08/10 13:40:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The analysis of immune response on the effect of endocrine therapy in breast cancer patients

Acronym

Immune response on the effect of endocrine therapy in breast cancer patients

Scientific Title

The analysis of immune response on the effect of endocrine therapy in breast cancer patients

Scientific Title:Acronym

Immune response on the effect of endocrine therapy in breast cancer patients

Region

Japan


Condition

Condition

Breast cancer

Classification by specialty

Breast surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Analyse the immune response during endocrine therapy in breast cancer patients

Basic objectives2

Others

Basic objectives -Others

Exploratory research

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Immune response on the effect of endocrine therapy

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

21 years-old <=

Age-upper limit

85 years-old >=

Gender

Female

Key inclusion criteria

Breast cancer patients undergoing sugery folloed by endcrine therapy

Key exclusion criteria

Patinets who received systemic therapy before surgery

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshiya Horimoto

Organization

Juntendo University School of Medicine

Division name

Breast Oncology

Zip code


Address

2-1-1 Hongo, Bunkyo-ku, Tokyo

TEL

03-3813-3111

Email

yoshiyahorimoto@hotmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Yoshiya Horimoto

Organization

Juntendo University School of Medicine

Division name

Breast Oncology

Zip code


Address

2-1-1 Hongo, Bunkyo-ku, Tokyo

TEL

03-3813-3111

Homepage URL


Email

yoshiyahorimoto@hotmail.com


Sponsor or person

Institute

Juntendo University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Grants-in-Aid for Scientific Research

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 08 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2015 Year 07 Month 30 Day

Date of IRB


Anticipated trial start date

2015 Year 08 Month 17 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Investigate patient outcomes


Management information

Registered date

2015 Year 08 Month 10 Day

Last modified on

2015 Year 08 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021534


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name